Stay updated on Daratumumab Combo in Resistant Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo in Resistant Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo in Resistant Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Multiple myeloma is added as a condition term and MedlinePlus Genetics is listed under related topics, enhancing disease context and discoverability. The site revision is updated to v3.6.3, replacing the previous v3.6.0.
    Difference
    0.2%
    Check dated 2026-07-03T22:17:31.000Z thumbnail image
  2. Check
    16 days ago
    No Change Detected
  3. Check
    24 days ago
    Change Detected
    Summary
    Recruitment status updated to closed with a new 'No longer looking for participants' notice. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and some headings/related topics were reformatted or removed.
    Difference
    0.4%
    Check dated 2026-06-12T16:15:55.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The platform was updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a minor software release of the site's underlying framework. This update does not change the displayed study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-06-05T10:41:30.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now explicitly presents the study's disease context by including 'Multiple myeloma' under the conditions. It also adds a 'related topics' section with MedlinePlus Genetics to connect readers with authoritative background information.
    Difference
    0.2%
    Check dated 2026-05-29T07:44:14.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    No additions or deletions are listed in the data, so there is no textual change to evaluate. The page content remains as previously captured, continuing to present the study's details about Daratumumab + Dexamethasone in resistant or refractory multiple myeloma.
    Difference
    0.0%
    Check dated 2026-05-22T08:49:48.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added, replacing the previous v3.5.3; this indicates an update to the page's underlying software/version label rather than a change to the study content.
    Difference
    0.0%
    Check dated 2026-05-15T02:18:48.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo in Resistant Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in Resistant Myeloma Clinical Trial page.